| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.024 | 0.6 |